Research news last week included Rocket Pharmaceuticals suffering a setback with its Phase II trial of RP-A501, which ...

The results show that ivonescimab in combination with chemotherapy demonstrated a statistically significant and clinically ...

Researchers at ASCO provided a look at DB-1310 and iza-bren in genomically altered NSCLC, amid an overall survival miss for ...

Pomerantz LLP is investigating claims on behalf of investors of Savara Inc. ("Savara" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ...

PMR/PMCs for studies and clinical trials occur after a drug or biologic product has been approved by the FDA. The 2007 FDA Amendments Act (FDAAA) specifically provided the FDA with the authority to ...

THIS SPRING, the National Institutes of Health quietly began terminating programs at scores of colleges that prepared ...